Literature DB >> 23701069

Comparison of liquid crystal display monitors calibrated with gray-scale standard display function and with γ 2.2 and iPad: observer performance in detection of cerebral infarction on brain CT.

Kumiko Yoshimura1, Takashi Nihashi, Mitsuru Ikeda, Yoshio Ando, Hisashi Kawai, Kenichi Kawakami, Reiko Kimura, Yumiko Okada, Yoshiyuki Okochi, Naotoshi Ota, Kenichi Tsuchiya, Shinji Naganawa.   

Abstract

OBJECTIVE: The purpose of the study was to compare observer performance in the detection of cerebral infarction on a brain CT using medical-grade liquid crystal display (LCD) monitors calibrated with the gray-scale standard display function and with γ 2.2 and using an iPad with a simulated screen setting.
MATERIALS AND METHODS: We amassed 97 sample sets, from 47 patients with proven cerebral infarction and 50 healthy control subjects. Nine radiologists independently assessed brain CT on a gray-scale standard display function LCD, a γ 2.2 LCD, and an iPad in random order over 4-week intervals. Receiver operating characteristic (ROC) analysis was performed by using the continuous scale, and the area under the ROC curve (A(z)) was calculated for each monitor.
RESULTS: The A(z) values for gray-scale standard display function LCD, γ 2.2 LCD, and iPad were 0.875, 0.884, and 0.839, respectively. The difference among the three monitors was very small. There was no significant difference between gray-scale standard display function LCD and γ 2.2 LCD. However, the A(z) value was statistically significantly smaller for the iPad than the γ 2.2 LCD (p < 0.05).
CONCLUSION: Observer performance for detecting cerebral infarction on the LCD with γ 2.2 calibration was found to be similar to the LCD with gray-scale standard display function calibration. Although observer performance using the iPad was poorer than that using the other LCDs, the difference was small. Therefore, the iPad could not substitute for other LCD monitors. However, owing to the promising potential advantages of tablet PCs, such as portability, further examination is needed into the clinical use of tablet PCs.

Entities:  

Mesh:

Year:  2013        PMID: 23701069     DOI: 10.2214/AJR.12.9096

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

1.  Effect of display type, DICOM calibration and room illuminance in bitewing radiographs.

Authors:  Soili Kallio-Pulkkinen; Sisko Huumonen; Marianne Haapea; Esa Liukkonen; Annina Sipola; Osmo Tervonen; Miika T Nieminen
Journal:  Dentomaxillofac Radiol       Date:  2015-08-03       Impact factor: 2.419

Review 2.  Radiological interpretation of images displayed on tablet computers: a systematic review.

Authors:  L J Caffery; N R Armfield; A C Smith
Journal:  Br J Radiol       Date:  2015-04-17       Impact factor: 3.039

3.  Reliability of diagnosing acute ischemic cerebrovascular on magnetic resonance imaging disorders using iPads.

Authors:  Hidekazu Hattori; Yoshifumi Kuwayama; Yoshitaka Inui; Kazuhiro Murayama; Motoharu Hayakawa; Shinji Ito; Hiroshi Toyama
Journal:  Jpn J Radiol       Date:  2018-10-13       Impact factor: 2.374

4.  Effect of display type and room illuminance in chest radiographs.

Authors:  Esa Liukkonen; Airi Jartti; Marianne Haapea; Heljä Oikarinen; Lauri Ahvenjärvi; Seija Mattila; Terhi Nevala; Kari Palosaari; Marja Perhomaa; Miika T Nieminen
Journal:  Eur Radiol       Date:  2015-12-10       Impact factor: 5.315

5.  Ruling Out Brain CT Contraindications prior to Intravenous Thrombolysis: Diagnostic Equivalence between a Primary Interpretation Workstation and a Mobile Tablet Computer.

Authors:  Antonio J Salazar; Nicolás Useche; Manuel Granja; Aníbal J Morillo; Sonia Bermúdez
Journal:  Int J Telemed Appl       Date:  2017-11-09

6.  Mobile device for thrombolysis decisions for telestroke.

Authors:  Antonio J Salazar; Nicolás Useche; Manuel F Granja; Aníbal J Morillo; Sonia Bermúdez; Didier Sossa; Claudia J Ortiz; Oscar J Torres; Brenda Ropero
Journal:  Colomb Med (Cali)       Date:  2018-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.